nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—GRIN2C—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0345	0.0345	CbGpPWpGaD
Amantadine—GRIN2C—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0345	0.0345	CbGpPWpGaD
Amantadine—DDC—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.0326	0.0326	CbGpPWpGaD
Amantadine—GRIN2D—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0321	0.0321	CbGpPWpGaD
Amantadine—GRIN2D—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0321	0.0321	CbGpPWpGaD
Amantadine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0316	0.0316	CbGpPWpGaD
Amantadine—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0293	0.0293	CbGpPWpGaD
Amantadine—MAOB—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.0274	0.0274	CbGpPWpGaD
Amantadine—GRIN2A—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0263	0.0263	CbGpPWpGaD
Amantadine—GRIN2A—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0263	0.0263	CbGpPWpGaD
Amantadine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0241	0.0241	CbGpPWpGaD
Amantadine—GRIN1—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.023	0.023	CbGpPWpGaD
Amantadine—GRIN1—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.023	0.023	CbGpPWpGaD
Amantadine—GRIN2C—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0225	0.0225	CbGpPWpGaD
Amantadine—GRIN2B—CREB phosphorylation through the activation of CaMKII—CAMK2B—osteoarthritis	0.0224	0.0224	CbGpPWpGaD
Amantadine—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—CAMK2B—osteoarthritis	0.0224	0.0224	CbGpPWpGaD
Amantadine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.021	0.021	CbGpPWpGaD
Amantadine—GRIN2D—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0209	0.0209	CbGpPWpGaD
Amantadine—GRIN2C—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0208	0.0208	CbGpPWpGaD
Amantadine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—CAMK2B—osteoarthritis	0.0205	0.0205	CbGpPWpGaD
Amantadine—GRIN2D—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0193	0.0193	CbGpPWpGaD
Amantadine—GRIN2C—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0185	0.0185	CbGpPWpGaD
Amantadine—GRIN2D—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0172	0.0172	CbGpPWpGaD
Amantadine—GRIN2A—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0172	0.0172	CbGpPWpGaD
Amantadine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0171	0.0171	CbGpPWpGaD
Amantadine—GRIN2A—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0159	0.0159	CbGpPWpGaD
Amantadine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0159	0.0159	CbGpPWpGaD
Amantadine—GRIN1—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.015	0.015	CbGpPWpGaD
Amantadine—GRIN2B—CREB phosphorylation through the activation of Ras—CAMK2B—osteoarthritis	0.0146	0.0146	CbGpPWpGaD
Amantadine—GRIN2A—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0141	0.0141	CbGpPWpGaD
Amantadine—GRIN1—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0138	0.0138	CbGpPWpGaD
Amantadine—GRIN2B—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.0135	0.0135	CbGpPWpGaD
Amantadine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.013	0.013	CbGpPWpGaD
Amantadine—GRIN1—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.0123	0.0123	CbGpPWpGaD
Amantadine—GRIN2B—Post NMDA receptor activation events—CAMK2B—osteoarthritis	0.012	0.012	CbGpPWpGaD
Amantadine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0114	0.0114	CbGpPWpGaD
Amantadine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CAMK2B—osteoarthritis	0.0111	0.0111	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—SOX9—osteoarthritis	0.00952	0.00952	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00639	0.00639	CbGpPWpGaD
Amantadine—DRD2—Hypothetical Network for Drug Addiction—CAMK2B—osteoarthritis	0.00635	0.00635	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00594	0.00594	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—COL2A1—osteoarthritis	0.00505	0.00505	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00488	0.00488	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0048	0.0048	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00446	0.00446	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00425	0.00425	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2B—osteoarthritis	0.00415	0.00415	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—GSTO1—osteoarthritis	0.00396	0.00396	CbGpPWpGaD
Amantadine—DDC—Dopaminergic Neurogenesis—TGFB1—osteoarthritis	0.00383	0.00383	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—CAMK2B—osteoarthritis	0.00368	0.00368	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00366	0.00366	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—BMP2—osteoarthritis	0.00354	0.00354	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00351	0.00351	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—BMP2—osteoarthritis	0.00345	0.00345	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—CAMK2B—osteoarthritis	0.00342	0.00342	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.0032	0.0032	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00312	0.00312	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL1RN—osteoarthritis	0.00302	0.00302	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—IL1B—osteoarthritis	0.00293	0.00293	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—CAMK2B—osteoarthritis	0.00281	0.00281	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—COL9A2—osteoarthritis	0.00278	0.00278	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—IL1B—osteoarthritis	0.00273	0.00273	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL1A—osteoarthritis	0.00272	0.00272	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—COL9A2—osteoarthritis	0.00271	0.00271	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—COL9A1—osteoarthritis	0.0027	0.0027	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—COL9A1—osteoarthritis	0.00263	0.00263	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00253	0.00253	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—CAMK2B—osteoarthritis	0.00245	0.00245	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—CAMK2B—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—IL1B—osteoarthritis	0.00224	0.00224	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—LEP—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00217	0.00217	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP2—osteoarthritis	0.00213	0.00213	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TNF—osteoarthritis	0.00213	0.00213	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP2—osteoarthritis	0.00208	0.00208	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—COL9A2—osteoarthritis	0.00198	0.00198	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TNF—osteoarthritis	0.00198	0.00198	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—IL1B—osteoarthritis	0.00195	0.00195	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—COL9A2—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—COL9A1—osteoarthritis	0.00192	0.00192	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—IL1B—osteoarthritis	0.0019	0.0019	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—COL9A1—osteoarthritis	0.00188	0.00188	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—LEP—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00166	0.00166	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TNF—osteoarthritis	0.00162	0.00162	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—MMP9—osteoarthritis	0.0016	0.0016	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—MMP9—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—CAMK2B—osteoarthritis	0.00155	0.00155	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—PTGS2—osteoarthritis	0.00152	0.00152	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CXCL8—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TNF—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL1B—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Amantadine—DDC—Metabolism—FMOD—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TNF—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—IHH—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—MMP9—osteoarthritis	0.00134	0.00134	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00132	0.00132	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—CAMK2B—osteoarthritis	0.00127	0.00127	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—CAMK2B—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Amantadine—MAOB—Metabolism—FMOD—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGES—osteoarthritis	0.00114	0.00114	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TGFB1—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TNF—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.001	0.001	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGES—osteoarthritis	0.000962	0.000962	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.000957	0.000957	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—IL6—osteoarthritis	0.00083	0.00083	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—SMAD3—osteoarthritis	0.000827	0.000827	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.000822	0.000822	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—SMAD3—osteoarthritis	0.000806	0.000806	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTO1—osteoarthritis	0.000805	0.000805	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP2—osteoarthritis	0.000792	0.000792	CbGpPWpGaD
Amantadine—DDC—Metabolism—BGN—osteoarthritis	0.00078	0.00078	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.000772	0.000772	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP2—osteoarthritis	0.000772	0.000772	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—MCF2L—osteoarthritis	0.000768	0.000768	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—LEP—osteoarthritis	0.000707	0.000707	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IHH—osteoarthritis	0.000697	0.000697	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MCF2L—osteoarthritis	0.000697	0.000697	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—LEP—osteoarthritis	0.000689	0.000689	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTO1—osteoarthritis	0.000678	0.000678	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—LEP—osteoarthritis	0.000666	0.000666	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.000664	0.000664	CbGpPWpGaD
Amantadine—MAOB—Metabolism—BGN—osteoarthritis	0.000657	0.000657	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—IL6—osteoarthritis	0.000631	0.000631	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—FMOD—osteoarthritis	0.000626	0.000626	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—MMP9—osteoarthritis	0.000596	0.000596	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—FMOD—osteoarthritis	0.000584	0.000584	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—MMP9—osteoarthritis	0.000581	0.000581	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.000578	0.000578	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP2—osteoarthritis	0.000565	0.000565	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.000555	0.000555	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP2—osteoarthritis	0.000551	0.000551	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGES—osteoarthritis	0.000511	0.000511	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGES—osteoarthritis	0.000476	0.000476	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000431	0.000431	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MMP9—osteoarthritis	0.000425	0.000425	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MMP9—osteoarthritis	0.000414	0.000414	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IHH—osteoarthritis	0.000412	0.000412	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MCF2L—osteoarthritis	0.000412	0.000412	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00041	0.00041	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.000403	0.000403	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—CXCL8—osteoarthritis	0.000391	0.000391	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—IL6—osteoarthritis	0.00037	0.00037	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—IL6—osteoarthritis	0.000361	0.000361	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTO1—osteoarthritis	0.00036	0.00036	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000355	0.000355	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TGFB1—osteoarthritis	0.00035	0.00035	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—BGN—osteoarthritis	0.000348	0.000348	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—FMOD—osteoarthritis	0.000342	0.000342	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TGFB1—osteoarthritis	0.000341	0.000341	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTO1—osteoarthritis	0.000335	0.000335	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—osteoarthritis	0.000327	0.000327	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—BGN—osteoarthritis	0.000325	0.000325	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.000311	0.000311	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—COL9A2—osteoarthritis	0.000302	0.000302	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000294	0.000294	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—COL9A1—osteoarthritis	0.000294	0.000294	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGES—osteoarthritis	0.000279	0.000279	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—IL6—osteoarthritis	0.000264	0.000264	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—IL6—osteoarthritis	0.000257	0.000257	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—IL6—osteoarthritis	0.000249	0.000249	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—CXCL8—osteoarthritis	0.000236	0.000236	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MMP3—osteoarthritis	0.000236	0.000236	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—osteoarthritis	0.000224	0.000224	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000213	0.000213	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BMP2—osteoarthritis	0.000201	0.000201	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000199	0.000199	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTO1—osteoarthritis	0.000197	0.000197	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—BGN—osteoarthritis	0.00019	0.00019	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP3—osteoarthritis	0.000139	0.000139	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCL8—osteoarthritis	0.000134	0.000134	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SMAD3—osteoarthritis	0.000126	0.000126	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCL8—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LEP—osteoarthritis	0.000108	0.000108	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ESR1—osteoarthritis	0.000103	0.000103	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FN1—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—osteoarthritis	0.0001	0.0001	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—osteoarthritis	9.34e-05	9.34e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1—osteoarthritis	8.91e-05	8.91e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL8—osteoarthritis	7.17e-05	7.17e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—osteoarthritis	6.82e-05	6.82e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—osteoarthritis	6.48e-05	6.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—osteoarthritis	5.47e-05	5.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—osteoarthritis	5.34e-05	5.34e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—osteoarthritis	4.03e-05	4.03e-05	CbGpPWpGaD
